Patent Intelligence
Where the next patent cliff and IP whitespace are.
Where are the risks and opportunities?
Live monitoring of patent expiry, generic and biosimilar entry windows, and IP strategy intelligence by therapy area and molecule.
Built for
- Strategy & corporate planning
- Generic / biosimilar players
- BD and licensing
- IP counsel & advisors
Core decision
"Where are the IP risks and opportunities?"
The decision journey
How decisions get made here.
1
Step 1
Patent Expiry
Live patent cliff tracking by molecule and geography.
2
Step 2
Generic & Biosimilar Entry
Generic competition and biosimilar opportunity assessment.
3
Step 3
IP Strategy
IP whitespace, lifecycle management and freedom-to-operate intelligence.
Working session
Bring one decision. We’ll show you how to answer it.
Walk us through the question your team is stuck on. In one session we’ll outline the data, model and dashboard that turns it into a defensible answer — and what shipping that system looks like.
Bring your decision